SciVision Biotech reports Sep revenue NT$61.1M
SciVision Biotech Inc. reported September revenue of NT$61,102,000 versus NT$60,337,000, and Jan–Sep revenue of NT$619,019,000 versus NT$635,232,000, per Taiwan Stock Exchange figures.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.